These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39427518)
1. Design, synthesis and biological evaluation of novel benzimidazole-derived p21-activited kinase 4 (PAK4) inhibitors bearing a 4-(4-methylpiperazin-1-yl)phenyl scaffold as potential antitumor agents. Hao S; Hou L; Wang JH; Yan JH; Niu YF; Cai ZH; Li F; Meng FH Eur J Med Chem; 2024 Dec; 280():116971. PubMed ID: 39427518 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 4-aminophenol-1,3,4-oxadiazole derivative potentiates apoptosis by targeting MAP kinase in triple negative breast cancer cells. Dhanalakshmi B; Anil Kumar BM; Muddenahalli Srinivasa S; Vivek HK; Sennappan M; Rangappa S; Srinivasa Murthy V J Biomol Struct Dyn; 2024; 42(23):13114-13129. PubMed ID: 37948299 [TBL] [Abstract][Full Text] [Related]
3. Discovery of 4-(4-(3-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazole-2-yl)isoxazol-5-yl)phenyl)morpholine as a novel c-Myc inhibitor against lung cancer in vitro and in vivo. Gao J; Yin J; Li S; Jia P; Hong R; Chen J; Qu X; Zhang Z; Li M; Zhao H Eur J Med Chem; 2025 Jan; 281():117023. PubMed ID: 39531932 [TBL] [Abstract][Full Text] [Related]
4. Discovery of novel diaryl urea-oxindole hybrids as BRAF kinase inhibitors targeting BRAF and KRAS mutant cancers. Ghannam IAY; El Kerdawy AM; Mounier MM; Abo-Elfadl MT; Abdel-Mohsen HT Bioorg Chem; 2024 Dec; 153():107848. PubMed ID: 39368145 [TBL] [Abstract][Full Text] [Related]
5. Muti-target rationale design of novel substituted N-phenyl-2-((6-phenylpyridazin-3-yl)thio)acetamide candidates as telomerase/JAK1/STAT3/TLR4 inhibitors: In vitro and in vivo investigations. Shaldam MA; Mousa MHA; Tawfik HO; El-Dessouki AM; Sharaky M; Saleh MM; Alzahrani AYA; Moussa SB; Al-Karmalawy AA Bioorg Chem; 2024 Dec; 153():107843. PubMed ID: 39332072 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of S-alkylated oxadiazole bearing imidazo[2,1-b]thiazole derivatives targeting breast cancer: In vitro cytotoxic evaluation and in vivo radioactive tracing studies. Mohammed ER; Abdel Fattah Ezzat M; Seif EM; Essa BM; Abdel-Aziz HA; Sakr TM; Ibrahim HS Bioorg Chem; 2024 Dec; 153():107935. PubMed ID: 39504637 [TBL] [Abstract][Full Text] [Related]
7. Discovery of flavonoid-containing compound Lupalbigenin as anti-NSCLC cancer agents via suppression of EGFR and ERK1/2 pathway. Cuan X; Yang X; Wang J; Sheng J; Wang X; Huang Y Bioorg Chem; 2024 Dec; 153():107808. PubMed ID: 39288634 [TBL] [Abstract][Full Text] [Related]
8. Novel 5-Fluorouracil analogues versus perfluorophenyl ureas as potent anti-breast cancer agents: Design, robust synthesis, in vitro, molecular docking, pharmacokinetics ADMET analysis and dynamic simulations. Sroor FM; El-Sayed AF; Mahmoud K Bioorg Chem; 2024 Dec; 153():107944. PubMed ID: 39532011 [TBL] [Abstract][Full Text] [Related]
9. Developing new anticancer agents: Design, synthesis, biological evaluation and in silico study of several functionalized pyrimidine-5-carbonitriles as small molecules modulators targeting breast cancer. Badawi WA; Okda TM; Abd El Wahab SM; Ezz-ElDien ES; AboulWafa OM Bioorg Chem; 2024 Dec; 153():107953. PubMed ID: 39556931 [TBL] [Abstract][Full Text] [Related]
10. Virtual screening, molecular dynamics simulations, and in vitro validation of EGFR inhibitors as breast cancer therapeutics. Shetty SR; Debnath S; Majumdar K; Rajagopalan M; Ramaswamy A; Das A Bioorg Chem; 2024 Dec; 153():107849. PubMed ID: 39368144 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and in silico insights of novel N'-(2-oxoindolin-3-ylidene)piperidine-4-carbohydrazide derivatives as VEGFR-2 inhibitors. Eldehna WM; Habib YA; Mahmoud AE; Barghash MF; Elsayed ZM; Elsawi AE; Maklad RM; Rashed M; Khalil A; Hammad SF; Ali MM; El Kerdawy AM Bioorg Chem; 2024 Dec; 153():107829. PubMed ID: 39317037 [TBL] [Abstract][Full Text] [Related]
13. Tetrahydrocarbazoles incorporating 5-arylidene-4-thiazolinones as potential antileukemia and antilymphoma targeting tyrosine kinase and tubulin polymerase enzymes: Design, synthesis, structural, biological and molecular docking studies. Ali BS; Mohammed AF; Kariuki BM; El-Awady R; H M Abdu-Allah H Bioorg Chem; 2024 Dec; 153():107817. PubMed ID: 39278066 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and structural proof of novel oxazolo[5,4-d]pyrimidine derivatives as potential VEGFR2 inhibitors. In vitro study of their anticancer activity. Sochacka-Ćwikła A; Regiec A; Czyżnikowska Ż; Śliwińska-Hill U; Kwiecień A; Wiatrak B; Rusak A; Krawczyńska K; Mrozowska M; Borska S; Ratajczak K; Pyra A; Mączyński M Bioorg Chem; 2024 Dec; 153():107958. PubMed ID: 39561438 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, molecular modeling and evaluation of 2,4-diaminopyrimidine analogues as promising colorectal cancer drugs. Venkatesan G; Yong Ping C; Chen H; Srinivasan P; Karkhanis AV; Pastorin G Bioorg Chem; 2024 Dec; 153():107854. PubMed ID: 39368143 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of anticancer activity of new 4,5,6,7-tetrabromo-1H-benzimidazole derivatives. Łukowska-Chojnacka E; Fedorov E; Kowalkowska A; Wielechowska M; Sobiepanek A; Koronkiewicz M; Wińska P Bioorg Chem; 2024 Dec; 153():107880. PubMed ID: 39476601 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
18. A potent Bioorganic azapodophyllotoxin derivative Suppresses tumor Progression in Triple negative breast Cancer: An Insight into its Inhibitory effect on tubulin polymerization and Disruptive effect on microtubule assembly. Gupta S; Dev J R A; Prakash Prasad C; Kumar A; Kumar Ghosh S Bioorg Chem; 2024 Dec; 153():107839. PubMed ID: 39326339 [TBL] [Abstract][Full Text] [Related]
19. Novel purine derivatives as selective CDK2 inhibitors with potential anticancer activities: Design, synthesis and biological evaluation. Shah A; Teraiya N; Kamdar JH; Juneja T; Sangani CB; Ahmed S; Kapadiya K Bioorg Chem; 2024 Dec; 153():107841. PubMed ID: 39326340 [TBL] [Abstract][Full Text] [Related]